Mission Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MISSION PHARMA, and when can generic versions of MISSION PHARMA drugs launch?
MISSION PHARMA has sixteen approved drugs.
There is one US patent protecting MISSION PHARMA drugs.
Drugs and US Patents for Mission Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mission Pharma | THIOLA | tiopronin | TABLET;ORAL | 019569-001 | Aug 11, 1988 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mission Pharmacal | THIOLA EC | tiopronin | TABLET, DELAYED RELEASE;ORAL | 211843-001 | Jun 28, 2019 | AB | RX | Yes | No | 11,458,104 | ⤷ Try a Trial | ⤷ Try a Trial | |||
Mission Pharma | HOMAPIN-10 | homatropine methylbromide | TABLET;ORAL | 086308-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.